通过REXO4-RNaseH1介导的内分和外分离合模式进行R循环处理,防止基因组不稳定性和抗瘤免疫力
Han Yang1, Chen Nie1, Yingyu Qin1
1Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Science advances
|February 18, 2026
概括
研究人员发现了外核酶REXO4,它与RNaseH1合作,降解R环,这对基因组稳定性和癌症至关重要. 这一发现为R循环处理和潜在的癌症疗法提供了新的见解.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- R环代谢与基因组稳定性和瘤发育有关.
- 了解R循环调节对于癌症研究至关重要.
研究的目的:
- 为了确定涉及R环退化的新型因素.
- 阐明R循环处理的机制及其在癌症中的作用.
主要方法:
- 对外核酶REXO4.4的鉴定和表征.
- 对REXO4与RNaseH1.1合作的分析.
- 全基因组的R循环分析.
- 瘤突变分析.
- 药物敏感性测试. 药物敏感性测试.
主要成果:
- REXO4以"内/外分离合"的方式与RNaseH1合作,降低R循环.
- REXO4降解RNA链并刺激RNaseH1活动.
- 缺少REXO4导致R环负荷增加和瘤突变.
- 发现了一种新的REXO4抑制剂 (REXO4-IN-17).
- 抑制REXO4可以提高对化疗的敏感性,并激活抗瘤免疫力.
结论:
- 提出了一种涉及"内/外分离合"的新型R循环处理模型.
- 通过调节R环,REXO4在维持基因组稳定性方面发挥着至关重要的作用.
- 向REXO4为癌症治疗和免疫治疗提供了潜在的治疗策略.
更多相关视频
06:10A Fluorescence-based Exonuclease Assay to Characterize DmWRNexo, Orthologue of Human Progeroid WRN Exonuclease, and Its Application to Other Nucleases
Published on: December 23, 2013
5.7K
09:16Analysis of RNA Processing Reactions Using Cell Free Systems: 3' End Cleavage of Pre-mRNA Substrates in vitro
Published on: May 3, 2014
13.2K
相关概念视频
Experimental RNAi
8.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
Homologous Recombination
64.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.1K
Restarting Stalled Replication Forks
6.4K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.4K
Conservative Site-specific Recombination and Phase Variation
6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.9K
Ribozymes
13.5K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.5K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K
